Related Experiment Video
Updated: Sep 5, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer
1Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Abstract:
The BRCA1-PALB2-BRCA2 axis plays essential roles in the cellular response to DNA double-strand breaks (DSB), maintenance of genome integrity, and suppression of cancer development. Upon DNA damage, BRCA1 is recruited to DSBs, where it facilitates end resection and recruits PALB2 and its associated BRCA2 to load the central recombination enzyme RAD51 to initiate homologous recombination (HR) repair. In recent years, several BRCA1-independent mechanisms of PALB2 recruitment have also been reported. Collectively, these available data illustrate a series of hierarchical, context-dependent, and cooperating mechanisms of PALB2 recruitment that is critical for HR and therapy response either in the presence or absence of BRCA1. Here, we review these BRCA1-dependent and independent mechanisms and their importance in DSB repair, cancer development, and therapy. As BRCA1-mutant cancer cells regain HR function, for which PALB2 is generally required, and become resistant to targeted therapies, such as PARP inhibitors, targeting BRCA1-independent mechanisms of PALB2 recruitment represents a potential new avenue to improve treatment of BRCA1-mutant tumors.
Insights
The BRCA1-PALB2-BRCA2 pathway is crucial for DNA repair and cancer suppression. Targeting BRCA1-independent PALB2 recruitment offers a new strategy to treat BRCA1-mutant cancers resistant to therapies.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The BRCA1-PALB2-BRCA2 axis is vital for DNA double-strand break (DSB) repair and maintaining genome stability.
- This pathway suppresses cancer development by facilitating homologous recombination (HR) repair.
Purpose of the Study:
- To review BRCA1-dependent and independent mechanisms of PALB2 recruitment.
- To highlight the importance of these mechanisms in DSB repair, cancer, and therapy response.
- To explore targeting BRCA1-independent PALB2 recruitment for treating BRCA1-mutant tumors.
Main Methods:
- Literature review of existing studies on BRCA1, PALB2, and BRCA2 functions.
- Analysis of BRCA1-dependent and independent PALB2 recruitment pathways.
- Evaluation of the role of PALB2 in homologous recombination and therapeutic resistance.
Main Results:
- BRCA1 recruits PALB2 and BRCA2 to DSBs to initiate HR repair.
- BRCA1-independent mechanisms for PALB2 recruitment have been identified.
- PALB2 recruitment is critical for HR and therapy response, irrespective of BRCA1 status.
Conclusions:
- Hierarchical and cooperating mechanisms govern PALB2 recruitment for effective HR repair.
- Targeting BRCA1-independent PALB2 recruitment is a promising therapeutic strategy for BRCA1-mutant cancers.
- This approach may overcome resistance to targeted therapies like PARP inhibitors in BRCA1-mutant tumors.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Long-patch Base Excision Repair
Restarting Stalled Replication Forks
Homologous Recombination
Base Excision Repair
The first step of...
Fixing Double-strand Breaks

